Annemieke M. Boot

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Journal: European journal of endocrinology

Published: January 20, 2026

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

Journal: European journal of endocrinology

Published: January 20, 2026

HRQoL in Adolescents with Idiopathic Isolated GHD: rhGH (Dis)continuation in Mid-Puberty.

HRQoL in Adolescents with Idiopathic Isolated GHD: rhGH (Dis)continuation in Mid-Puberty.

Journal: Endocrine connections

Published: December 03, 2025

Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents With Transient Idiopathic GHD.

Growth Hormone Withdrawal in Mid-Puberty: No Impact on Near Adult Height in Adolescents With Transient Idiopathic GHD.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 15, 2025

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

Journal: PloS one

Published: September 24, 2025

Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth.

Journal: Orphanet journal of rare diseases

Published: September 04, 2025

Clinical Characteristics and Response to Growth Hormone Treatment in 27 Children With Heterozygous NPR2 Variants: Real-World Data.

Clinical Characteristics and Response to Growth Hormone Treatment in 27 Children With Heterozygous NPR2 Variants: Real-World Data.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 10, 2025

Quantified Fluorescence Imaging for the Perfusion of the Parathyroid Glands of Children (FLUOPATCH): A Multicenter, Proof-of-Concept Study.

Quantified Fluorescence Imaging for the Perfusion of the Parathyroid Glands of Children (FLUOPATCH): A Multicenter, Proof-of-Concept Study.

Journal: Journal of pediatric surgery

Published: February 03, 2025

Global Learner Feedback on Continuing Medical Education-Accredited e-Learning Modules in Pediatric Endocrinology and Diabetes: Cross-Sectional Study.

Global Learner Feedback on Continuing Medical Education-Accredited e-Learning Modules in Pediatric Endocrinology and Diabetes: Cross-Sectional Study.

Journal: JMIR medical education

Published: October 12, 2024

Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment.

Tertiary hyperparathyroidism in two paediatric patients with X-linked hypophosphatemia during Burosumab treatment.

Journal: Bone

Published: June 30, 2024

Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients.

Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients.

Journal: Calcified tissue international

Published: September 12, 2023

Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes.

Fibroblast growth factor 23 and calcium-phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes.

Journal: Journal of diabetes

Published: July 24, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026